Cutler Group’s Neurotrope, Inc. Common NTRP Stock Holding History

Cutler Group’s Portfolio NTRP Stock Details NTRP Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2020 Q2	–	Sell	-1,900	Closed	-$7K	–	5152
2020 Q1	$7K	Hold	1,900	–	–	﹤0.01%	2956
2019 Q4	$7K	Hold	1,900	–	–	﹤0.01%	2893
2019 Q3	$8K	Buy	+1,900	New	+$8.71K	﹤0.01%	2788
2018 Q2	–	Sell	-1,700	Closed	-$4K	–	5196
2018 Q1	$4K	Sell	1,700 -1,600	-48%	-$12.7K	﹤0.01%	3488
2017 Q4	$2K	Buy	3,300 +800	+32%	+$4.66K	﹤0.01%	4289
2017 Q3	$6K	Buy	2,500 +1,800	+257%	+$9.45K	﹤0.01%	4299
2017 Q2	$6K	Buy	+700	New	+$7.48K	﹤0.01%	4739

Other funds holding NTRP

SPIA

Steward Partners Investment Advisory New York $19.6B AUM 22.89% 1-Year Est. Return

Cutler Group's NTRP Position: Q4 2020 in Review

Cutler Group sold out of Neurotrope, Inc. Common (NTRP) in Q4 2020, closing a stake of 2,200 shares — an estimated $2K sold.

Cutler Group first reported a position in NTRP in Q2 2017 and held it in 12 quarters. The position peaked at $54K in Q2 2019. 1 fund tracked by Wall St. Rank holds NTRP as of Q4 2020.

Cutler Group reported no remaining Neurotrope, Inc. Common position as of Q4 2020 after selling out during the quarter.
Cutler Group sold 2,200 Neurotrope, Inc. Common shares in Q4 2020, an estimated $2K.
Cutler Group first reported a position in Neurotrope, Inc. Common in Q2 2017 and held it in 12 quarters.
Cutler Group's Neurotrope, Inc. Common position peaked at $54K in Q2 2019.
1 fund tracked by Wall St. Rank held Neurotrope, Inc. Common as of Q4 2020.

Based on Cutler Group's 13F filing for Q4 2020, filed 21 Jan 2021.